About this trial
This study is conducted to evaluate the safety and performance of robot-assisted microsurgical anastomoses with the MUSA-3 system.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient age ≥ 18 years.
Patients requiring procedures involving micro-anastomosis of small anatomical structures-such as blood vessels, nerves, or lymphatic vessels-in free flap, lymphatic, or peripheral nerve surgery.
Patients who have been selected by the research team at the Clinical Center as appropriate candidates for treatment with MUSA-3 in accordance with the IFU.
Able to give informed consent before participating in the study.
Disqualifiers
Subject participates in a potentially confounding drug or device trial during the course of the study.
Patients that are pregnant or breastfeeding.
≥ISL (International Society of Lymphology) Stage III lymphedema
History of marcaine or indocyanine green allergy
Trial design
Single group
Treatments tested in this trial
Robot-assisted microsurgical anastomoses
DeviceFirst in human study
Treatment groups
Trial outcomes
Primary outcomes
Safety: device-related adverse events (AEs)
Performance: conversion rate to manual procedure
Clinical performance: vessel patency rate
Secondary outcomes
Anastomosis quality (SAMS score)
The quality of the anastomosis assessed with the Structured Assessment of Microsurgery Skills (SAMS) score.
Anastomosis time
Duration of the full anastomosis from the moment of piercing the vessel wall for the first stitch until the thread of the last stitch is cut.
Locations
This trial is not recruiting at the moment. You can still explore other options: